home / stock / pure / pure news

PURE News and Press, PURE Bioscience From 03/15/24

Stock Information
Company Name: PURE Bioscience
Stock Symbol: PURE
Market: OTC
Website: purebio.com
Menu
PURE PURE Quote PURE Short PURE News PURE Articles PURE Message Board
Get PURE Alerts

News, Short Squeeze, Breakout and More Instantly...
PURE - Expected US Company Earnings on Friday, March 15th, 2024

Tredegar Corporation (TG) is expected to report for quarter end 2023-12-31 Pharma-Bio Serv Inc (PBSV) is expected to report $0.02 for Q1 2024 Telos Corporation (TLS) is expected to report $-0.18 for Q4 2023 Coretec Group Inc (CRTG) is expected to report for quarter end 2023-12-31 ...
PURE - PURE Stock Earnings: PURE Bioscience Reported Results for Q1 2024

2023-12-18 11:51:52 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips PURE Bioscience (OTCMKTS: PURE ) just reported results for the first quarter of 2024. PURE Bioscience reported earnings per share of -1 cent. The company reported reve...

PURE - PURE Bioscience GAAP EPS of -$0.01, revenue of $0.72M

2023-12-14 17:02:55 ET More on PURE Bioscience Financial information for PURE Bioscience For further details see: PURE Bioscience GAAP EPS of -$0.01, revenue of $0.72M

PURE - PURE Bioscience Reports Fiscal First Quarter 2024 Financial Results

Update on Business and PURE’s SDC-Based Antimicrobial Food Safety Solutions PURE Bioscience, Inc. ( OTCQB: PURE ) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial...
PURE - Expected US Company Earnings on Wednesday, December 13th, 2023

Epiroc AB ADR (EPOKY) is expected to report for Q3 2023 Sysmex Corporation ADR (SSMXY) is expected to report for Q2 2024 Streamline Health Solutions Inc. (STRM) is expected to report for Q1 2024 Helix Biopharma Corp. (HBPCF) is expected to report for Q2 2024 Standard Chartered plc...

PURE - PURE Bioscience GAAP EPS of -$0.04, revenue of $1.87M

2023-10-30 17:32:19 ET More on PURE Bioscience Financial information for PURE Bioscience For further details see: PURE Bioscience GAAP EPS of -$0.04, revenue of $1.87M

PURE - PURE Bioscience Reports Fiscal 2023 Financial Results

Update on Business and PURE’s SDC-Based Antimicrobial Food Safety Solutions PURE Bioscience, Inc. ( OTCQB: PURE ) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial...
PURE - Expected US Company Earnings on Friday, October 27th, 2023

FNCB Bancorp Inc. (FNCB) is expected to report for Q1 2024 Civista Bancshares Inc. (CIVB) is expected to report $0.6 for Q3 2023 ASLAN Pharmaceuticals Limited (ASLN) is expected to report $-0.85 for Q3 2023 Grupo Televisa S.A. (TV) is expected to report $0.02 for Q3 2023 Red River...

PURE - Expected earnings - Pure Bioscience Inc

Pure Bioscience Inc (PURE) is expected to report for quarter end 2023-07-31

PURE - PURE Bioscience to unveil "PURE Genius" Food Safety Program at the Annual International Association for Food Protection Meeting

July 16 th -19 th , 2023, Toronto, Ontario, Canada Booth #530 PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, is set to unveil its “PURE Genius” food safety program at the 2023 Intern...
Previous 10 Next 10